1. Abenova M, Shaltynov A, Jamedinova U, Semenova Y. Worldwide child
routine vaccination hesitancy rate among parents of children aged 0–6 years:
a systematic review and meta-analysis of cross-sectional studies. Vaccines.
2023;12(1): 31.
2. Tate J, Aguado T, Belie JD, Holt D, Karafillakis E, Larson HJ, et al. The life-course
approach to vaccination: harnessing the benefits of vaccination throughout
life. Vaccine. 2019;37(44):6581–3.
3. Doherty M, Buchy P, Standaert B, Giaquinto C, Prado-Cohrs D. Vaccine impact:
benefits for human health. Vaccine. 2016;34(52):6707–14.
4. Vanderslott S, Dattani S, Spooner F., Roser M. Vaccination. OurWorldInData.
org; 2015. Available from: https://ourworldindata.org/vaccination.
5. Tomljenovic H, Bubic A, Erceg N. It just doesn’t feel right - the relevance of
emotions and intuition for parental vaccine conspiracy beliefs and vaccina�tion uptake. Psychol Health. 2020;35(5):538–54.
6. Suppli CH, Hansen ND, Rasmussen M, Valentiner-Branth P, Krause TG, Mølbak
K. Decline in HPV-vaccination uptake in Denmark - the association between
HPV-related media coverage and HPV-vaccination. BMC Public Health.
2018;18(1):1360.
7. Wise J. Child vaccination rates drop in England as MMR uptake falls for fourth
year. BMJ (Online). 2018;362: k3967.
8. Ather F, Sherin A. Vaccine hesitancy: A threat to vaccine preventable disease
programs. Khyber Med Univ J. 2019;11(2):65–6. https://doi.org/10.35845/kmu
j.2019.19538.
9. McGregor S, Goldman RD. Determinants of parental vaccine hesitancy. Can
Fam Physician. 2021;67(5):339–41.
10. Haroune V, King L. Factors contributing to parental ‘vaccine hesitancy’ for
childhood immunisations. Nurs Child Young People. 2020;32(4):20–5.
11. Giambi C, Fabiani M, D’Ancona F, Ferrara L, Fiacchini D, Gallo T, et al.
Parental vaccine hesitancy in Italy– Results from a National survey. Vaccine.
2018;36(6):779–87.
12. Deal A, Halliday R, Crawshaw AF, Hayward SE, Burnard A, Rustage K, et al.
Migration and outbreaks of vaccine-preventable disease in europe: a system�atic review. Lancet Infect Dis. 2021;21(12):e387–98.
13. Habersaat KB, Pistol A, Stanescu A, Hewitt C, Grbic M, Butu C, et al. Measles
outbreak in Romania: understanding factors related to suboptimal vaccina�tion uptake. Eur J Public Health. 2020;30(5):986–92.
14. Henszel L, Kanitz EE, Grisold A, Holzmann H, Aberle SW, Schmid D. Vaccina�tion status and attitude among measles cluster cases in Austria, 2019. Int J
Environ Res Public Health. 2020;17(24): 9377.
15. Woudenberg T, van Binnendijk RS, Sanders EAM, Wallinga J, de Melker HE,
Ruijs WLM, et al. Large measles epidemic in the Netherlands, May 2013 to
March 2014: changing epidemiology. Euro Surveill. 2017;22(3):11–9.
16. Mchale P, Keenan A, Ghebrehewet S. Reasons for measles cases not being
vaccinated with MMR: investigation into parents’ and carers’ views following a
large measles outbreak. Epidemiol Infect. 2016;144(4):870–5.
17. Toure A, Saadatian-Elahi M, Floret D, Lina B, Casalegno J, Vanhems P. Knowl�edge and risk perception of measles and factors associated with vaccina�tion decisions in subjects consulting university affiliated public hospitals in
lyon, france, after measles infection. Hum Vaccines Immunotherapeutics.
2014;10(6):1755–61.
18. Knol M, Urbanus A, Swart E, Mollema L, Ruijs WL, Binnendijk, RSV et al. Large
ongoing measles outbreak in a religious community in the Netherlands since
May 2013. Euro Surveill. 2013;18(36):pii=20580.
19. López Hernández B, Laguna Sorinas J, Marín Rodríguez I, Gallardo García V,
Pérez Morilla E, Mayoral Cortés JM. Spotlight on measles 2010: An ongoing
outbreak of measles in an unvaccinated population in Granada, Spain, Octo�ber to November 2010. Euro Surveill. 2010;15(50):19746.
20. World Health Organization EpiBrief. A report on the epidemiology of selected
vaccine-preventable diseases in the European Region. https://www.who.in
t/europe/publications/i/item/WHO-EURO-2023-7691-47458-69761. 2023.
Accessed 10 Jan 2024.
21. World Health Organization EpiData. A monthly summary of the epidemio�logical data on selected vaccine-preventable diseases in the WHO European
Region. https://www.who.int/europe/publications/m/item/epidata-7-2023.
2023. Accessed 7 Jan 2024.
22. Burki T. Measles in Europe. Lancet Infect Dis. 2018;18(10):1070–1.
23. Robert A, Funk S, Kucharski AJ. The measles crisis in Europe—the need for a
joined-up approach. Lancet (British edition). 2019;393(10185):2033.
24. Muscat M, Gebrie B, Efstratiou A, Datta SS, Daniels D. Diphtheria in the WHO
European Region, 2010 to 2019. Euro surveillance: bulletin européen sur les
maladies transmissibles. 2022;27(8):1.
25. Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger
M. COSMOS-E: guidance on conducting systematic reviews and meta-analy�ses of observational studies of etiology. PLoS Med. 2019;16(2):e1002742.
26. Rasmussen I, Wallace S, Mengshoel AT, Høiby EA, Brandtzæg P.
Diphtheria outbreak in Norway: lessons learned. Scand J Infect Dis.
2011;43(11–12):986–9.
27. Homola L, Klučka J, Helešic J, Jirsenská Z, Kratochvíl M, Dominik P, et al.
Unvaccinated child tetanus from nasal toy battery. Cent Eur J Public Health.
2021;29(4):322–4.
28. European Centre for Disease Prevention and Control. Vaccination schedules
for individual European countries and specific age groups. https://www.ec
dc.europa.eu/en/immunisation-vaccines/EU-vaccination-schedules. 2013.
Accessed 5 Dec 2023.
29. Lam T, Ranjan R, Newark K, Surana S, Bhangu N, Lazenbury A, et al. A recent
surge of fulminant and early onset subacute sclerosing panencephalitis
(SSPE) in the united kingdom: an emergence in a time of measles. Eur J
Pediatr Neurol. 2021;34:43–9.
30. Ferren M, Horvat B, Mathieu C. Measles encephalitis: towards new therapeu�tics. Viruses. 2019. https://doi.org/10.3390/v11111017.
31. Holt E. 41 000 measles cases in Europe since the beginning of 2018. Lancet
(British edition). 2018;392(10149):724.
32. Karafillakis E, Larson HJ, ADVANCE consortium. The benefit of the doubt or
doubts over benefits? A systematic literature review of perceived risks of vac�cines in European populations. Vaccine. 2017;35(37):4840–50.
33. Alsubaie SS, Gosadi IM, Alsaadi BM, Albacker NB, Bawazir MA, Bin-Daud N, et
al. Vaccine hesitancy among Saudi parents and its determinants. Result from
the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Med J.
2019;40(12):1242–50.
34. Ruijs WLM, Hautvast JLA, Ijzendoorn G, WJCv A, Kvd V, Hulscher MEJL. How
orthodox Protestant parents decide on the vaccination of their children: a
qualitative study. BMC Public Health. 2012;12(1):408.
35. Fournet N, Mollema L, Ruijs WL, Harmsen IA, Keck F, Durand JY, et al. Under�vaccinated groups in Europe and their beliefs, attitudes and reasons for
non-vaccination; two systematic reviews. BMC Public Health. 2018;18(1):196.
36. Harmsen IA, Ruiter RAC, Paulussen TGW, Mollema L, Kok G, de Melker HE.
Factors that influence vaccination decision-making by parents who visit an
anthroposophical child welfare center: a focus group study. Adv Prev Med.
2012;2012:175694–7.
37. Rose L, Browne M, Bryden G. Scepticism towards vaccination is associ�ated with anti-scientific attitudes and related cultural factors. Focus Altern
Complement Ther. 2016;21(1):58–9.
38. Duffell E. Attitudes of parents towards measles and immunisation after a
measles outbreak in an anthroposophical community. J Epidemiol Commu�nity Health (1979). 2001;55(9):685–6.
39. HANRATTY B, HOLT T, PATTERSON DUFFELLE, RAMSAY W, WHITE M. UK
measles outbreak in non-immune anthroposophic communities: the
implications for the elimination of measles from Europe. Epidemiol Infect.
2000;125(2):377–83.
40. Suijkerbuijk AW, Woudenberg T, Hahne SJ, Lochlainn LN, Melker HEd,
Ruijs WLM, et al. Economic costs of measles outbreak in the netherlands,
2013–2014. Emerg Infect Dis. 2015;21(11):2067–9.
41. Moser CA, Reiss D, Schwartz RL. Funding the costs of disease outbreaks
caused by non-vaccination. J Law Med Ethics. 2015;43(3):633–47.
42. Bruns R, Hosangadi D, Trotochaud M, Kirk Sell T. COVID‑19 vaccine misinfor�mation and disinformation costs an estimated $50 to $300 million each day.
Baltimore (MD): Johns Hopkins Center for Health Security; 2021.
43. Al-Tammemi AB, Tarhini Z. Beyond equity: advocating theory-based health
promotion in parallel with COVID-19 mass vaccination campaigns. Public
Health Pract (Oxford England). 2021;2:100142.
44. Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicat�ing with parents about vaccination: a framework for health professionals.
BMC Pediatr. 2012;12(1):154.
45. Attwell K, Smith DT, Ward PR. The unhealthy other’: how vaccine rejecting
parents construct the vaccinating mainstream. Vaccine. 2018;36(12):1621–6.
46. Cohen DA, Scribner RA, Farley TA. A structural model of health behavior: a
pragmatic approach to explain and influence health behaviors at the popula�tion level. Prev Med. 2000;30(2):146–54.
47. Goldenberg MJ. Vaccine hesitancy: Public trust, expertise, and the war on
science. Pittsburgh (PA): University of Pittsburgh Press; 2021.
48. Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, et al.
The unintended consequences of COVID-19 vaccine policy: why mandates,
passports and restrictions May cause more harm than good. BMJ Global
Health. 2022;7(5):e008684.
49. World Health Organization. Immunization Agenda 2030. https://cdn.who.int/
media/docs/defaultsource/immunization/strategy/ia2030/ia2030draft4wha_
b88503791fce4847bfd15d2c9d9e32f8.pdf?sfvrsn=5389656e_66&download=
true. 2020. Accessed 30 Jan 2024.
50. Albrecht D. Vaccination, politics and COVID-19 impacts. BMC Public Health.
2022;22(1):96